Description
+ Include: 63 (+5) Videos (.mp4) + 63 Subtitles (+5) (.vtt) + 54 PDFs, size: 14.72 (+88.49) GB
+ Target Audience: pulmonologists, intensivists, and critical care physicians, internists, hospital medicine physicians
+ Sample video: contact me for sample video
+ Information:
1. Overview
The Harvard Pulmonary And Critical Care Medicine 2026 course provides a comprehensive, evidence-based review of the latest advancements in pulmonary, critical care, and sleep medicine. The program equips clinicians with cutting-edge strategies for diagnosing and managing complex respiratory conditions, intensive care emergencies, and emerging therapeutics to improve patient outcomes in both outpatient and ICU settings.
Course Date: April 27, 2026 – May 1, 2026
Pulmonary and Critical Care Medicine 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and for patients requiring critical care.
Pulmonary and Critical Care Medicine is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.
This comprehensive course provides education and updates to optimize your care of patients with pulmonary conditions and patients requiring critical care. Physicians, NPs, and PAs can rely on this program to enhance their practice and advance their knowledge with evidence-based strategies for evaluation, diagnosis, treatment, and procedures.
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. This year’s program covers:
- New in 2026: breaking news updates in pulmonary and critical care medicine
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- Interventional pulmonology: diagnostic procedures, therapeutic interventions, and as an alternative to surgery
- High-flow oxygen therapy for respiratory failure
- Updates on biologics in asthma and other lung disease
- Diagnosis and management of bleeding diatheses in the ICU
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- New evidence on sedation, analgesia, and early mobility in the ICU
- Point-of-care pulmonary ultrasound in the intensive care unit
- Lung microbiome: emerging implications for lung health
- Emerging evidence for targeted temperature management
- Steroid-sparing agents for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Handling neurologic and surgical emergencies in the medical ICU
A Practical, Comprehensive Update for Busy Clinicians
This program delivers comprehensive updates to improve evaluation, diagnosis, and management of the broad array of pulmonary and critical care conditions:
- IPF
- Non-IPF ILD
- ARDS
- Sarcoidosis
- Lung transplantation
- Bronchiectasis
- Cystic fibrosis
- Lung nodules
- Lung cancer
- Sepsis
- Pleural disease
- Pneumonia
- Tuberculosis
- Thromboembolism
- COPD
- Asthma
- GERD
- Neurologic issues in the ICU
- Sleep-disordered breathing
- Surgical emergencies
- Acute pancreatitis
- Atypical mycobacterial disease
- Pulmonary hypertension
- Post-cardiac arrest care
- Hypersensitivity pneumonitis
- Ventilator management
Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.
2. Learning Objectives
- Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features
- Apply evidence from recent literature to clinical case management
- Apply new clinical practice guidelines to improve patient outcomes
- Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients
- Review the latest evidence and best clinical practices for fluid resuscitation and vasopressor use
3. Target Audience
Best for pulmonologists, intensivists, and critical care nurses who want updates on respiratory diseases, ICU management, and sleep medicine.
Who Should Participate
Physicians, Nurse Practitioners, and Physician Assistants in the fields of:
- Pulmonology
- Critical Care
- Internal Medicine
- Hospital Medicine
… and other medical professionals who want to advance their knowledge of pulmonary and critical care medicine
4. Topics
-
01 Breaking News in Pulmonary Medicine Dr. Benjamin Medof
-
02 Cystic Fibrosis Understanding CFTR and New Treatment Dr. Isabel Neuringer
-
03 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis Dr. Christopher Richards
-
04 Lung Transplantation 2026 Referral Patient Selection, Lung Allocation, and COVID Dr. Brian Keller
-
05 Exercise and Cardiopulmonary Disorders Indications and Interpretation Dr. C. Corey Hardin
-
06 Q&A with Speakers Drs. Isabel Neuringer, Christopher Richards, Brian Keller, and C. Corey Hardin
-
07 Pulmonary Pathology Interstitial Lung Disease Dr. Lida Hariri
-
08 Looking Deeper Patterns and Insights from Chest Radiology Dr. Amita Sharma
-
09 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD Dr. Barry Shea
-
10 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! Dr. Sydney Montesi
-
11 Treatment Challenges of Pulmonary Sarcoidosis Dr. Robert Hallowell
-
12 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs Dr. Grace Peloquin
-
13 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Barry Shea, Robert Hallowell, Grace Peloquin, and Sydney Montesi
-
14 Sedation, Analgesia, and Early Mobility The State ofthe Artin 2026 Dr. Crystal North
-
15 Noninvasive Respiratory Supportfor Acute Respiratory Failure Less May NOT Be Best Carolyn La Vita, MHA, RRT
-
16 Novel Ventilator Modes The Hype and Reality Carolyn La Vita, MHA, RRT
-
17 ARDS State-of-the-Art Strategies to Protectthe Lung Dr. Jehan Alladina
-
18 After the ICU Post-ICU Care Syndrome and Recovery Dr. George Alba
-
19 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Crystal North, George Alba, and Jehan Alladina, and Carolyn La Vita, MHA, RRT
-
20 From Ancient Egyptto Balanced Crystalloids Medicine’s Attempts to Manage Sepsis Dr. Eric Schmidt
-
21 Fluid Responsiveness Dr. David Ziehr
-
22 Vasopressors in Septic Shock Old Friends and New Dr. Jason Griffith
-
23 Approach to Empiric Antibiotics in the ICU Dr. Alyssa Letourneau
-
24 Approach to the Immunocompromised Critically Ill Patient Dr. Lisa Bebell
-
25 Renal Replacement Therapy in the ICU What and When to Start(or Not) Dr. Andrew Allegretti
-
26 Q&A with Speakers Drs. Kathryn Hibbert, Lisa Bebell, Alyssa Letourneau, David Ziehr, Eric Schmidt, Jason Griffith, and Andrew Allegretti
-
27 Common Neurologic Issues in the ICU Dr. Sahar Zafar
-
28 TTM and Neuro-prognostication After Cardiac Arrest Dr. David Greer
-
29 Surgical Emergencies in the Medical ICU Dr. Noelle Saillant
-
30 Updates in Management of Acute Pancreatitis Dr. Casey Luckhurst
-
31 Advanced Cardiac Supportin the ICU Dr. David Dudzinski
-
32 Q&A with Speakers Drs. Sahar Zafar, David Greer, Noelle Saillant, David Dudzinski, and Casey Luckhurst
-
33 Breaking Updates in Critical Care Dr. Kathryn Hibbert
-
34 Management ofthe Acutely Hemorrhaging Patient Dr. Raghu Chivkula
-
35 Point-of-Care Ultrasound in the Intensive Care Unit Dr. Jonah Rubin
-
36 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care Dr. Joshua Metlay
-
37 Prognosis and Uncertainty in the ICU Dr. Emily Rubin
-
38 Palliative Care in Advanced Lung Disease Dr. Jaclyn Shameklis
-
39 Q&A with Speakers Drs. Kathryn Hibbert, Emily Rubin, Joshua Metlay, Jaclyn Shameklis, and Jonah Rubin
-
40 Pleural Disease 2026 Updates Dr. Fayez Kheir
-
41 Interventional Pulmonology in 2026 Dr. Colleen Keyes
-
42 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond Dr. Colleen Keyes
-
43 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies Dr. Allison Chang
-
44 COPD 2026 Dr. Walter O’Donnell
-
45 Q&A with Speakers Drs. Angela Frank, Fayez Kheir, Colleen Keyes, and Walter O’Donnell
-
46 Aspergillus Lung Disease Dr. Rod Rahimi
-
47 Asthma What’s New in 2026 Dr. Miranda Theodore
-
48 New Therapeutics in Lung Disease The Age of Immunotherapy Dr. Benjamin Medof
-
49 A Strategic Approach to the Management of Pulmonary Nodules Dr. Angela Frank
-
50 Tuberculosis in 2026 Dr. Jodian Pinkney
-
51 Nontuberculous Mycobacterial Disease Navigating the Labyrinth Dr. Rocio Hurtado
-
52 Q&A with Speakers Drs. Kathryn Hibbert, Benjamin Medof, Rocio Hurtado, Angela Frank, Rod Rahimi, and Jodian Pinkney
-
53 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fitin 2026 Dr. Rachel Rosovsky
-
54 Pulmonary Embolism An Update Dr. Alison Witkin
-
55 Pulmonary Hypertension Categorization and Evaluation Dr. Josanna Rodriguez-Lopez
-
56 Pulmonary Hypertension Management Dr. Alexandra Wong
-
57 Vasculitis and ANCA Dr. Rachel Knipe
-
58 Q & A with Speakers Drs. Alison Witkin, Josanna Rodriguez-Lopez, Alexandra Wong, Angela Frank, and Rachel Rosovsky
-
59 Obstructive Sleep Apnea Dr. James Mojica
-
60 Central Sleep Apnea 2026 Dr. James Mojica
-
61 Sleep Diagnostics Dr. Katherine Dudley
-
62 Noninvasive Ventilation Dr. Katherine Dudley
-
63 Q & A with Speakers Drs. James Mojica and Katherine Dudley
Reviews
There are no reviews yet.